1-2 of 2
Stéphanie Herveau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells

Rouba Hage-Sleiman, Stéphanie Herveau, Eva-Laure Matera, Jean-Fabien Laurier, Charles Dumontet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (2): 303–312.
https://doi.org/10.1158/1535-7163.MCT-10-0568
Published: 08 February 2011
View article titled, Silencing of <em>Tubulin Binding Cofactor C</em> Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Open the PDF for Silencing of <em>Tubulin Binding Cofactor C</em> Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101

Stephane Dalle, Lina Reslan, Timothee Besseyre de Horts, Stephanie Herveau, Frank Herting, Adriana Plesa, Thomas Friess, Pablo Umana, Christian Klein, Charles Dumontet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (1): 178–185.
https://doi.org/10.1158/1535-7163.MCT-10-0385
Published: 10 January 2011
View article titled, Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101
Open the PDF for Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101 in another window
Includes: Supplementary data